Suven Pharmaceuticals Limited functions as a bio-pharmaceutical company with operations in India, the United States, Europe, and globally. The company specializes in the development, manufacturing, and sale of intermediates, active pharmaceutical ingredients, specialty chemicals, and formulated drugs based on new chemical entities. It provides contract research and manufacturing services for pharmaceutical, biotechnology, and chemical firms. Established in 2018, the company is headquartered in Hyderabad, India, and is a subsidiary of Jasti Property and Equity Holdings Private Limited.
Suven Pharmaceuticals Limited
- 1,097.80 -22.25(-1.99%) 1,090.00 -30.25(-2.70%)
Live Suven Pharmaceuticals Limited Share Price Chart
Suven Pharmaceuticals Limited Share Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,071.05 1,072.05 | 1,111.45 1118.85 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 598.00 (03-Jun-2024) 597.00 (04-Jun-2024) | 1,360.00 (02-Dec-2024) 1,359.00 (02-Dec-2024) |
- Open
- 1,100.00 1,118.85
- Previous Close
- 1,120.05 1,120.25
- Volume
- 3.56
- Total Traded value
- 38.61 (Lakhs)
- Upper circuit
- 1,344.05 859.20
- Lower circuit
- 896.05 572.80
Suven Pharmaceuticals Limited Share Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 184 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 1,089.65 | 184.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 184 |
Suven Pharmaceuticals Limited Share Fundamentals
| Market Cap: | 279.46 Cr |
| PE Ratio (TTM): | 98.64 |
| PB Ratio: | 12.58 |
| Industry P/E: | 102.05 |
| Debt to Equity: | 0.02 |
| ROE: | 12.75 |
| EPS (TTM): | 11.05 |
| Book Value: | 0.00 |
| Face Value: | 1.00 |
Suven Pharmaceuticals Limited Stock Financials
| Jun, 2023 | Dec, 2022 | Dec, 2022 | Dec, 2022 | Dec, 2022 | |
|---|---|---|---|---|---|
| Revenue | 1,130.54 Cr | 1,131.17 Cr | 8.46 Cr | 186.25 Cr | 348.49 Cr |
| Profit | 63.74 Cr | 111.43 Cr | 4.07 Cr | 14.71 Cr | 109.47 Cr |
| Expense | 1,080.22 Cr | 983.94 Cr | 3.06 Cr | 166.91 Cr | 213.72 Cr |
| Comprehensive income | 63.78 Cr | 111.05 Cr | 2.63 Cr | 14.68 Cr | 109.28 Cr |
| EPS | 8.67 | 17.10 | 3.82 | 5.89 | 4.30 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Suven Pharmaceuticals Limited | Mar, 2020 Mar, 2020 | Pharmaceuticals Pharmaceuticals | SUVENPHAR SUVENPHAR |
Suven Pharmaceuticals Limited Stock Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Suven Pharmaceuticals Limited Share FAQ's
What is the range of today's stock performance for Suven Pharmaceuticals Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,071.05 on the NSE (National Stock Exchange) to a maximum of 1,111.45. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,072.05 to a high of 1,118.85.
What are the 52-week low and high values for Suven Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 598.00 (occurred on 03-Jun-2024) and a high of 1,360.00 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 597.00 (on 04-Jun-2024), and the 52-week high is 1,359.00 (on 02-Dec-2024).
What was the opening and previous closing prices for Suven Pharmaceuticals Limited?
The stock's performance over the past 52 weeks reveals a low of 598.00 (occurred on 03-Jun-2024) and a high of 1,360.00 (achieved on 02-Dec-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 597.00 (on 04-Jun-2024), and the 52-week high is 1,359.00 (on 02-Dec-2024).
What is the total volume and traded value for Suven Pharmaceuticals Limited for the day?
The total volume is 4, and the total traded value is 38.61 ( Lakhs).
What are the upper and lower circuit limits for Suven Pharmaceuticals Limited?
The upper circuit limit is 1,344.05, and the lower circuit limit is 896.05.
What is the market cap and PE ratio for Suven Pharmaceuticals Limited?
The market cap is 279.46 Cr, and the PE ratio (TTM) is 102.05.
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Suven Pharmaceuticals Limited?
ROE is 12.75, EPS is 11.05, book value is not available
What are the revenue and profit figures for the latest quarter and previous quarters for Suven Pharmaceuticals Limited?
In Jun 2023, Revenue is 11305400000.00, and Profit is 637400000.00. In Dec 2022, Revenue is 11311670000.00, and Profit is 1114330000.00.
When was Suven Pharmaceuticals Limited listed, and what industry does it belong to?
The company, Suven Pharmaceuticals Limited, was listed in Mar 2020 and belongs to the Pharmaceuticals industry. Its NSE symbol is SUVENPHAR.
What is the current shareholding pattern of the Suven Pharmaceuticals Limited?
As of latest available update, promoters hold 60.00%, the public holds 40.00%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 39
- Threads
- 241
